Publications

Detailed Information

Interstitial Fluid Pressure as a Prognostic Factor in Cervical Cancer Following Radiation Therapy

DC Field Value Language
dc.contributor.authorYeo, Seung-Gu-
dc.contributor.authorKim, Jun-Sang-
dc.contributor.authorCho, Moon-June-
dc.contributor.authorKim, Ki-Hwan-
dc.contributor.authorKim, Jae-Sung-
dc.date.accessioned2012-06-15T05:38:46Z-
dc.date.available2012-06-15T05:38:46Z-
dc.date.issued2009-10-01-
dc.identifier.citationCLINICAL CANCER RESEARCH; Vol.15 19; 6201-6207ko_KR
dc.identifier.issn1078-0432-
dc.identifier.urihttps://hdl.handle.net/10371/77103-
dc.description.abstractPurpose: To investigate tumor interstitial fluid pressure as a prognostic factor for recurrence-free survival in patients with cervical cancer following radiation therapy. Experimental Design: Tumor interstitial fluid pressure was measured in 55 cervical cancer patients who received radiation therapy between August 1998 and September 2002. Interstitial fluid pressure measurements were made before radiation therapy (pre-radiation therapy interstitial fluid pressure) and after a median of 28.8 Gy in 16 fractions (range, 25.2-30.6 Gy in 14-17 fractions) of radiation therapy (mid-radiation therapy interstitial fluid pressure), using a modified wick-in-needle technique. Median follow-up was 74 months (range, 2-118 months). The Kaplan-Meier method with the log-rank test and Cox`s proportional hazard model were used in univariate and multivariate analyses, respectively, of prognostic factors for recurrence-free survival. Results: Median pre-radiation therapy and mid-radiation therapy interstitial fluid pressure were 29.0 mm Hg (range, 4.0-93.9 mm Hg) and 20.0 mm Hg (range, -1.2 to 29.6 mm Hg), respectively (P = 0.001). Pre-radiation therapy interstitial fluid pressure was significantly higher in adenocarcinomas than squamous cell carcinomas (P = 0.028). Significant reduction of interstitial fluid pressure was noted only in patients with complete responses (P = 0.002), and mid-radiation therapy interstitial fluid pressure was significantly lower in patients with complete responses (P = 0.036). In the multivariate analysis including interstitial fluid pressures and clinical variables, pre-radiation therapy interstitial fluid pressure was an independent prognostic factor for local and distant recurrence-free survival (P = 0.001 and 0.027, respectively). Conclusions: Mid-radiation therapy interstitial fluid pressure measurement may be useful in predicting radiation therapy responses, and pre-radiation therapy interstitial fluid pressure was a significant prognostic factor for local and distant relapse-free survival in patients with cervical cancer after radiation therapy. (Clin Cancer Res 2009;15(19):6201-7)ko_KR
dc.language.isoenko_KR
dc.publisherAMER ASSOC CANCER RESEARCHko_KR
dc.titleInterstitial Fluid Pressure as a Prognostic Factor in Cervical Cancer Following Radiation Therapyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor여승구-
dc.contributor.AlternativeAuthor김준상-
dc.contributor.AlternativeAuthor조문준-
dc.contributor.AlternativeAuthor김기환-
dc.contributor.AlternativeAuthor김재성-
dc.identifier.doi10.1158/1078-0432.CCR-09-0560-
dc.citation.journaltitleCLINICAL CANCER RESEARCH-
dc.description.citedreferenceFyles A, 2006, RADIOTHER ONCOL, V80, P132, DOI 10.1016/j.radonc.2006.07.014-
dc.description.citedreferenceMayr NA, 2006, AM J ROENTGENOL, V187, P65, DOI 10.2214/AJR.05.0039-
dc.description.citedreferenceWachsberger PR, 2005, CLIN CANCER RES, V11, P835-
dc.description.citedreferenceJain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819-
dc.description.citedreferenceHeldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456-
dc.description.citedreferenceWachsberger P, 2004, HEMATOL ONCOL CLIN N, V18, P1039, DOI 10.1016/j.hoc.2004.06.007-
dc.description.citedreferenceMilosevic A, 2004, SEMIN RADIAT ONCOL, V14, P249, DOI 10.1016/j.semradonc.2004.04.006-
dc.description.citedreferenceEifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197-
dc.description.citedreferenceWillett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988-
dc.description.citedreferenceThorpe PE, 2004, CLIN CANCER RES, V10, P415-
dc.description.citedreferenceRECOULESARCHE A, 2004, GYNECOL OBSTET FERTI, V32, P116-
dc.description.citedreferenceSalnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje-
dc.description.citedreferenceWachsberger P, 2003, CLIN CANCER RES, V9, P1957-
dc.description.citedreferenceGorski DH, 2003, CANCER RES, V63, P308-
dc.description.citedreferenceSiemann DW, 2002, INT J RADIAT ONCOL, V53, P164-
dc.description.citedreferenceMilosevic M, 2001, AM J CLIN ONCOL-CANC, V24, P516-
dc.description.citedreferenceMilosevic M, 2001, CANCER RES, V61, P6400-
dc.description.citedreferenceSantin AD, 1999, OBSTET GYNECOL, V94, P78-
dc.description.citedreferenceKeys HM, 1999, NEW ENGL J MED, V340, P1154-
dc.description.citedreferenceMilosevic MF, 1998, CANCER, V82, P2418-
dc.description.citedreferenceTokumo K, 1998, GYNECOL ONCOL, V68, P38-
dc.description.citedreferenceFerrara N, 1997, ENDOCR REV, V18, P4-
dc.description.citedreferenceBoucher Y, 1996, CANCER RES, V56, P4264-
dc.description.citedreferenceNieto FJ, 1996, AM J EPIDEMIOL, V143, P1059-
dc.description.citedreferenceEIFEL PJ, 1995, GYNECOL ONCOL, V59, P38-
dc.description.citedreferenceGUIDI AJ, 1995, J NATL CANCER I, V87, P1237-
dc.description.citedreferenceLESS JR, 1992, CANCER RES, V52, P6371-
dc.description.citedreferenceBOUCHER Y, 1992, CANCER RES, V52, P5110-
dc.description.citedreferenceGUTMANN R, 1992, CANCER RES, V52, P1993-
dc.description.citedreferenceBOUCHER Y, 1991, CANCER RES, V51, P6691-
dc.description.citedreferenceROH HD, 1991, CANCER RES, V51, P6695-
dc.description.citedreferenceBOUCHER Y, 1990, CANCER RES, V50, P4478-
dc.description.citedreferenceBAXTER LT, 1989, MICROVASC RES, V37, P77-
dc.description.citedreferenceJAIN RK, 1988, CANCER RES, V48, P7022-
dc.description.citedreferenceJAIN RK, 1987, CANCER RES, V47, P3039-
dc.description.citedreferenceMILLER AB, 1981, CANCER, V47, P207-
dc.description.tc5-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share